Editing Coronary artery disease (section)

===Surgery===
Revascularization for [[acute coronary syndrome]] has a mortality benefit.<ref>{{cite journal | vauthors = Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC | display-authors = 6 | title = ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) | journal = Circulation | volume = 106 | issue = 14 | pages = 1893–900 | date = October 2002 | pmid = 12356647 | doi = 10.1161/01.CIR.0000037106.76139.53 | doi-access = free }}</ref> Percutaneous revascularization for ''stable'' ischaemic heart disease does not appear to have benefits over medical therapy alone.<ref name="pmid24296791">{{cite journal | vauthors = Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL | display-authors = 6 | title = Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials | journal = JAMA Internal Medicine | volume = 174 | issue = 2 | pages = 232–40 | date = February 2014 | pmid = 24296791 | doi = 10.1001/jamainternmed.2013.12855 | doi-access = free }}<!--|access-date=26 October 2015--></ref> In those with disease in more than one artery, [[coronary artery bypass graft]]s appear better than [[percutaneous coronary intervention]]s.<ref name="pmid24296767">{{cite journal | vauthors = Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C | title = Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era | journal = JAMA Internal Medicine | volume = 174 | issue = 2 | pages = 223–30 | date = February 2014 | pmid = 24296767 | doi = 10.1001/jamainternmed.2013.12844 | doi-access = free }}</ref> Newer "anaortic" or no-touch off-pump coronary artery revascularization techniques have shown reduced postoperative stroke rates comparable to percutaneous coronary intervention.<ref>{{cite journal | vauthors = Zhao DF, Edelman JJ, Seco M, Bannon PG, Wilson MK, Byrom MJ, Thourani V, Lamy A, Taggart DP, Puskas JD, Vallely MP | display-authors = 6 | title = Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis | journal = Journal of the American College of Cardiology | volume = 69 | issue = 8 | pages = 924–36 | date = February 2017 | pmid = 28231944 | doi = 10.1016/j.jacc.2016.11.071 | doi-access = free }}</ref> Hybrid coronary revascularization has also been shown to be a safe and feasible procedure that may offer some advantages over conventional CABG though it is more expensive.<ref>{{cite journal | vauthors = Reynolds AC, King N | title = Hybrid coronary revascularization versus conventional coronary artery bypass grafting: Systematic review and meta-analysis | journal = Medicine | volume = 97 | issue = 33 | pages = e11941 | date = August 2018 | pmid = 30113498 | pmc = 6112891 | doi = 10.1097/MD.0000000000011941 }}</ref>